| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 99 |
| Guru Rank Value : 10.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
114,804 |
160,028 |
233,441 |
670,548 |
| Total Sell Value |
$63,971,895 |
$85,688,289 |
$125,298,991 |
$310,286,863 |
| Total People Sold |
8 |
9 |
14 |
17 |
| Total Sell Transactions |
17 |
23 |
61 |
140 |
| End Date |
2025-10-09 |
2025-07-08 |
2025-01-07 |
2024-01-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Brosius Mark |
See Remarks |
|
2025-12-15 |
4 |
AS |
$548.49 |
$254,499 |
D/D |
(464) |
131 |
|
- |
|
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2025-12-15 |
4 |
AS |
$548.49 |
$254,499 |
D/D |
(464) |
443 |
|
- |
|
Brosius Mark |
See Remarks |
|
2025-12-12 |
4/A |
AS |
$547.36 |
$170,776 |
D/D |
(312) |
595 |
|
- |
|
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2025-12-12 |
4 |
AS |
$547.36 |
$2,463,120 |
D/D |
(4,500) |
907 |
|
- |
|
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2025-12-12 |
4 |
OE |
$79.64 |
$358,370 |
D/D |
4,500 |
5,407 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-12-01 |
4 |
AS |
$568.99 |
$71,124 |
D/D |
(125) |
0 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-12-01 |
4 |
OE |
$208.90 |
$26,113 |
D/D |
125 |
125 |
|
- |
|
Guthart Gary S |
Executive Chair of the Board o |
|
2025-12-01 |
4 |
AS |
$570.89 |
$13,019,722 |
D/D |
(22,806) |
2,694 |
|
- |
|
Guthart Gary S |
Executive Chair of the Board o |
|
2025-12-01 |
4 |
OE |
$139.52 |
$3,557,760 |
D/D |
25,500 |
25,500 |
|
- |
|
Barratt Craig H |
Director |
|
2025-11-12 |
4 |
AS |
$580.00 |
$435,000 |
D/D |
(750) |
0 |
|
- |
|
Barratt Craig H |
Director |
|
2025-11-12 |
4 |
OE |
$71.32 |
$53,492 |
D/D |
750 |
750 |
|
- |
|
Charlton Henry L |
EVP & Chief Commercial and Mkt |
|
2025-11-12 |
4 |
AS |
$580.00 |
$7,963,980 |
D/D |
(13,731) |
3,056 |
|
- |
|
Charlton Henry L |
EVP & Chief Commercial and Mkt |
|
2025-11-12 |
4 |
OE |
$177.99 |
$2,069,552 |
D/D |
9,000 |
10,688 |
|
- |
|
Leonard Keith R |
Director |
|
2025-11-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,606 |
739 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-11-10 |
4 |
AS |
$560.00 |
$58,800 |
D/D |
(105) |
0 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-11-10 |
4 |
OE |
$229.39 |
$24,086 |
D/D |
105 |
105 |
|
- |
|
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2025-11-10 |
4 |
AS |
$575.00 |
$2,012,500 |
D/D |
(3,500) |
5,758 |
|
- |
|
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2025-11-10 |
4 |
OE |
$208.90 |
$757,746 |
D/D |
3,500 |
7,960 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2025-11-05 |
4 |
AS |
$550.00 |
$1,136,850 |
D/D |
(2,067) |
473 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2025-11-05 |
4 |
OE |
$59.46 |
$156,368 |
D/D |
2,067 |
632 |
|
- |
|
Rosa David J. |
Chief Executive Officer (CEO) |
|
2025-11-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,454 |
228,802 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-10-29 |
4 |
AS |
$543.00 |
$67,875 |
D/D |
(125) |
0 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-10-29 |
4 |
OE |
$208.90 |
$26,113 |
D/D |
125 |
125 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-10-28 |
4 |
AS |
$548.43 |
$4,147,193 |
D/D |
(7,562) |
353 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2025-10-28 |
4 |
OE |
$208.90 |
$1,771,513 |
D/D |
7,562 |
1,732 |
|
- |
|
1453 Records found
|
|
Page 1 of 59 |
|
|